Tateo, V., Jong, J. D., Cigliola, A., Maiorano, B. A., Mercinelli, C., Crupi, E., Raggi, D., Giannatempo, P., Colecchia, M., Moschini, M., Davicioni, E., Briganti, A., Montorsi, F., Santini, D., Necchi, A. (2025). The estrogen response pathway as a putative predictive biomarker of neoadjuvant pembrolizumab benefit in patients with muscle-invasive bladder carcinoma (MIBC).. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2025.43.5_suppl.843